Cargando…
Co-expression of ING4 and P53 enhances hypopharyngeal cancer chemosensitivity to cisplatin in vivo
Hypopharyngeal cancer is a distinct type of malignant head and neck tumor, which exhibits low sensitivity to anti-cancer drugs. The importance of developing methods for reducing chemotherapy resistance, and improving and enhancing prognosis has previously been emphasized and is considered a challeng...
Autores principales: | Ren, Xin, Liu, Hao, Zhang, Mingjie, Wang, Mengjun, Ma, Shiyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991689/ https://www.ncbi.nlm.nih.gov/pubmed/27484725 http://dx.doi.org/10.3892/mmr.2016.5552 |
Ejemplares similares
-
Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
por: Wang, Xiaolin, et al.
Publicado: (2023) -
Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53
por: Liu, Rongfeng, et al.
Publicado: (2021) -
Pparg may Promote Chemosensitivity of Hypopharyngeal Squamous Cell Carcinoma
por: Lian, Meng, et al.
Publicado: (2020) -
Microarray gene expression analysis of chemosensitivity for docetaxel, cisplatin and 5-fluorouracil (TPF) combined chemotherapeutic regimen in hypopharyngeal squamous cell carcinoma
por: Lian, Meng, et al.
Publicado: (2017) -
Chloroquine-Enhanced Efficacy of Cisplatin in the Treatment of Hypopharyngeal Carcinoma in Xenograft Mice
por: Zhao, Xing-guo, et al.
Publicado: (2015)